Gallium-68
Showing 1 - 25 of 655
Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)
Not yet recruiting
- Advanced Gastroenteropancreatic Neuroendocrine Tumor
- (no location specified)
Oct 16, 2023
Myocardial Fibrosis Trial in Nanjing (68Ga/18F-FAPI-04)
Recruiting
- Myocardial Fibrosis
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
May 11, 2023
Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)
Recruiting
- Neuroendocrine Tumors
- Gallium-68 NODAGA-JR11
-
Beijing, Beijing, China
- +1 more
Jul 27, 2022
Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography
Recruiting
- Hepatocellular Carcinoma
- Gallium Ga 68 Gozetotide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023
Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,
Recruiting
- Ganglioneuroblastoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Metastatic Trial in Ann Arbor (68Ga-PSMA)
Active, not recruiting
- Prostate Cancer
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan
Mar 10, 2022
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed
Not yet recruiting
- Metastatic Prostate Carcinoma
- +4 more
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy
Enrolling by invitation
- Castration-Resistant Prostate Carcinoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Infective Endocarditis Trial in Bordeaux (68Ga-citrate PET/CT)
Not yet recruiting
- Infective Endocarditis
- 68Ga-citrate PET/CT
-
Bordeaux, FranceCHU de Bordeaux
Jul 6, 2022
Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)
Recruiting
- Meningioma
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 28, 2022
Neuroendocrine Tumors Trial in Beijing (Gallium-68 NODAGA-LM3 PET/CT, Gallium-68 DOTA-LM3 PET/CT, Gallium-68 DOTATATE PET/CT)
Completed
- Neuroendocrine Tumors
- Gallium-68 NODAGA-LM3 PET/CT
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Dec 20, 2021
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)
Recruiting
- Bladder Cancer
- [68Ga]-NOTA-SGC8
-
Shanghai, Shanghai, ChinaRenji Hospital
Aug 14, 2023
Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)
Suspended
- Biochemically Recurrent Prostate Carcinoma
- Gallium Ga 68-labeled PSMA-11
- Positron Emission Tomography
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Breast Cancer Stage IV Trial in Irvine (Gallium-68)
Recruiting
- Breast Cancer Stage IV
- Gallium-68
-
Irvine, CaliforniaHoag Memorial Hospital Presbyterian
May 26, 2023
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los
Terminated
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Terminated
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022
Metastic Thyroid Cancer Trial run by the NIDDK (68-Gallium-DOTATATE-PET/CT)
Recruiting
- Metastic Thyroid Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission
Recruiting
- Solid Tumors, Adult
- Metastatic Cancer
- Gallium-68 labelled (68Ga-) FAP-2286
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 1, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- CT (Computed Tomography)
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 3, 2022